These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 18288733)

  • 21. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
    Spies C; Reissmann U; Timmermanns I; Schräder R
    J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
    Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.
    Lin MC; Fu YC; Jan SL; Lin WW; Chu KH; Ting CT; Chen YT; Chi CS
    Acta Paediatr Taiwan; 2005; 46(1):17-23. PubMed ID: 16302572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure.
    Durongpisitkul K; Tang NL; Soongswang J; Laohaprasitiporn D; Nana A; Kangkagate C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S658-66. PubMed ID: 12403244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter closure of patent foramen ovale associated with atrial septal aneurysm with Amplatzer Cribriform septal occluder.
    Musto C; Cifarelli A; Pandolfi C; De Felice F; Fiorilli R; Caferri G; Violini R
    J Invasive Cardiol; 2009 Jun; 21(6):290-3. PubMed ID: 19494408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interatrial shunt closure devices in patients with nickel allergy.
    Reddy BT; Patel JB; Powell DL; Michaels AD
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
    Spies C; Strasheim R; Timmermanns I; Schraeder R
    Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter closure of perforated secundum atrial septal defect under intracardiac echocardiographic guidance using a single amplatzer device: feasibility of a new method.
    Zanchetta M; Rigatelli G; Pedon L; Zennaro M; Carrozza A; Onorato E
    J Invasive Cardiol; 2005 May; 17(5):262-5. PubMed ID: 15879606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PFO closure in 2008: See through a glass, darkly.
    Carroll JD
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):388-9. PubMed ID: 18288736
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
    Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closure of persistent foramen ovale with the BioSTAR biodegradable PFO closure device: feasibility and long-term outcome.
    Karagianni A; Abrahamsson P; Furenäs E; Eriksson P; Dellborg M
    Scand Cardiovasc J; 2011 Oct; 45(5):267-72. PubMed ID: 21728789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic outcome of percutaneous transcatheter patent foramen ovale closure with Left-disk-coated patent foramen ovale occluder].
    Huang YG; Zhang CJ; Huang XS; Huang T; Huang WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1132-5. PubMed ID: 20193187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.